DCM
SAGE

DAFNA Capital Management’s Sage Therapeutics SAGE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-108,200
Closed -$860K 80
2025
Q1
$860K Hold
108,200
0.24% 62
2024
Q4
$588K Hold
108,200
0.15% 70
2024
Q3
$781K Sell
108,200
-8,000
-7% -$57.8K 0.18% 67
2024
Q2
$1.26M Buy
+116,200
New +$1.26M 0.3% 58
2024
Q1
Sell
-245,000
Closed -$5.31M 80
2023
Q4
$5.31M Buy
+245,000
New +$5.31M 1.27% 24
2023
Q3
Sell
-180,306
Closed -$8.48M 78
2023
Q2
$8.48M Hold
180,306
2.32% 16
2023
Q1
$7.57M Hold
180,306
2.27% 13
2022
Q4
$6.88M Hold
180,306
1.94% 15
2022
Q3
$7.06M Hold
180,306
1.9% 18
2022
Q2
$5.82M Hold
180,306
1.59% 18
2022
Q1
$5.97M Hold
180,306
1.56% 18
2021
Q4
$7.67M Hold
180,306
1.93% 13
2021
Q3
$7.99M Buy
180,306
+10,000
+6% +$443K 2.12% 12
2021
Q2
$9.68M Sell
170,306
-11,000
-6% -$625K 2.02% 8
2021
Q1
$13.6M Hold
181,306
3.22% 5
2020
Q4
$15.7M Buy
181,306
+23,000
+15% +$1.99M 4.67% 4
2020
Q3
$9.68M Sell
158,306
-7,000
-4% -$428K 3.15% 6
2020
Q2
$6.87M Hold
165,306
1.98% 14
2020
Q1
$4.75M Buy
165,306
+40,500
+32% +$1.16M 1.98% 14
2019
Q4
$9.01M Hold
124,806
3.09% 8
2019
Q3
$17.5M Buy
124,806
+1,000
+0.8% +$140K 6.58% 2
2019
Q2
$22.7M Hold
123,806
8.52% 2
2019
Q1
$19.7M Buy
123,806
+19,500
+19% +$3.1M 8.49% 2
2018
Q4
$9.99M Buy
104,306
+5,000
+5% +$479K 4.97% 3
2018
Q3
$14M Buy
99,306
+3,306
+3% +$467K 5.76% 3
2018
Q2
$15M Buy
96,000
+2,000
+2% +$313K 7.04% 2
2018
Q1
$15.1M Buy
94,000
+65,200
+226% +$10.5M 7.37% 2
2017
Q4
$4.74M Buy
+28,800
New +$4.74M 2.55% 13